Heritage Global Partners is selling biopharma lab equipment from FibroGen. The auction takes place in conjunction with American Laboratory Trading. FibroGen develops therapies for the treatment of conditions including locally advanced pancreatic cancer, metastatic pancreatic cancer, prostate cancer, anaemia and chemotherapy induced anaemia. The online auction opens on the 14th of November and bidding closes on the 15th of November.
Lots available include: ABI 4000 Q-Trap LC-MA system with Shimadzu HPLC, Kuhner triple stack CO2 incubator/shaker, 2022 Sartorius bioreactor, 2021 Cytivia AKTA Avant 25, 2021 Shimadzu LC-MS 8050 system (triple quadrupole) with Shimadzu HPLC system, 2021 Shimadzu Nexera HPLC system, Beckman Coulter/AB Sciex PA800 Plus, 2021 Molecular Devices Spectramax ABS Plus system, Luminex CellStream flow cytometer, Miltenyi gentleMACS octo dissociator, Waters UPLC system, (3) Beckman Coulter J26 centrifuge, Molecular Devices Spectramax M5 and more.
The assets are located in Hayward, California and can be inspected by appointment with the auctioneer only.
Headquartered in San Diego, California Heritage Global Partners is a full-service auctioneering company managing sales at all scales – from single assets through to complete turnkey facilities and factories. Heritage Global Partners works with clients across 28 different manufacturing, financial and technology industries, including the electronics, pharmaceutical, energy and food and beverage sectors.